Steps towards equitable lung cancer care, but barriers remain

Publicly released:
New Zealand
Image by  Marcelo Leal via UnSplash
Image by Marcelo Leal via UnSplash

Differences in access to good lung cancer care may be an important driver of lower survival rates for Māori. Māori with lung cancer also have higher emergency presentation rates, poorer access to early detection, lower surgery rates and disparities in the distance required to travel to treatment. However, a Viewpoint article in the New Zealand Medical Journal also found some cause for cautious celebration, including equitable access to a bronchoscopy, pathological diagnosis, radiation therapy and systemic therapy, as well as minimal differences in the timing of treatment between ethnic groups.

Media release

From: Pasifika Medical Association Group

Lung cancer is the most common cause of cancer death for Māori, and Māori are less likely to survive lung cancer than NZ Europeans with the same cancer. Differences between Māori and NZ Europeans in access to good cancer care might be an important driver of this survival disparity. We found that Māori with lung cancer have higher emergency presentation rates, poorer access to early detection, lower surgery rates and disparities in the distance required to travel to bronchoscopy, surgery and radiation therapy. However, we also found some cause for cautious celebration, including equitable access to a bronchoscopy, pathological diagnosis, radiation therapy and systemic therapy, as well as minimal differences in the timing of treatment between ethnic groups.

Journal/
conference:
New Zealand Medical Journal
Organisation/s: University of Otago, University of Waikato, Te Whatu Ora - Health New Zealand, University of Auckland
Funder: We would like to acknowledge the investment from Te Aho o Te Kahu – Cancer Control Agency, the Ministry of Health and the Health Research Council that enabled this research.
Media Contact/s
Contact details are only visible to registered journalists.